What they were paid
Corbus Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $72,582 | $35,616 | $107,584 | $0 | $215,782 |
| FY2024 | $60,000 | $115,495 | $113,329 | — | $288,824 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Corbus Pharmaceuticals Holdings, Inc. DEF 14A filed April 2, 2026, accession 0001193125-26-140363, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance
The rest of the Corbus Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anne Altmeyer | Independent Director | $193,846 |
| John Jenkins | Independent Director | $208,200 |
| Winston Kung | Independent Director | $203,200 |
| Yong Ben | Independent Director | $195,700 |
| Yuval Cohen | Director | $0 |
The full Corbus Pharmaceuticals compensation record
free company briefThis page is one director within Corbus Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat